APA (7th ed.) Citation

P, M., T, D., J, H., MA, H., AK, M., AE, R., & RR, M. (2026). The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer. The oncologist, 31(7), . https://doi.org/10.1093/oncolo/oyag173

Chicago Style (17th ed.) Citation

P, Mulugeta, Dorff T, Hafron J, Huynh MA, Morgans AK, Ross AE, and McKay RR. "The Emerging Role of Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Hormone-sensitive Prostate Cancer." The Oncologist 31, no. 7 (2026). https://doi.org/10.1093/oncolo/oyag173.

MLA (9th ed.) Citation

P, Mulugeta, et al. "The Emerging Role of Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Hormone-sensitive Prostate Cancer." The Oncologist, vol. 31, no. 7, 2026, https://doi.org/10.1093/oncolo/oyag173.